Larimar Therapeutics LRMR
NASDAQ LRMR
$3.19 +0.05 (+1.75%)
As of: Sep 30, 2026 · 3:59 PM EDT

Larimar Therapeutics (LRMR) Interest Expenses (2014 - 2020)

Updated

Larimar Therapeutics' Interest Expenses came in at $301,000 for Q1 2020, down 39.8% from $500,000 a year earlier and down 16.9% from the prior quarter.

Analysis

Larimar Therapeutics (LRMR) Interest Expenses (2014 - 2020) Analysis & Trends

Over the trailing twelve months to Mar 31, 2020, Larimar Therapeutics reported Interest Expenses of $1.57 million, down 19.2% year-over-year; for FY2019, it came in at $1.77 million, down 7.0% from FY2018.

  • Interest Expenses carries a five-year compound annual growth rate of 15.2% (FY2014 to FY2019).
  • Going back by year, Interest Expenses was $1.9 million in FY2018, $165,000 in FY2017 (-68.8%), $529,000 in FY2016 (-34.4%) and $806,000 in FY2015 (-7.4%).
  • The Q1 2020 figure represents the lowest quarterly Interest Expenses since Q4 2017.
  • Year-over-year, Interest Expenses has declined for three consecutive quarters, with growth averaging 118.9% over the last six quarters.
  • The fastest year-over-year change in Interest Expenses over five years came in Q2 2018 (growth of 779.2%), and the weakest in Q4 2017 (a decline of 91.8%).
  • Business Quant data shows LRMR's Interest Expenses at $362,000 (Q4 2019), $426,000 (Q3 2019) and $478,000 (Q2 2019) in the three quarters before Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 281.00 Mn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -435.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 247.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Larimar Therapeutics 326.19 Mn -280.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 301,000.00
Dec 31, 2019 362,000.00
Sep 30, 2019 426,000.00
Jun 30, 2019 478,000.00
Mar 31, 2019 500,000.00
Dec 31, 2018 499,000.00
Sep 30, 2018 475,000.00
Jun 30, 2018 466,000.00
Mar 31, 2018 458,000.00
Dec 31, 2017 8,000.00
Sep 30, 2017 31,000.00
Jun 30, 2017 53,000.00
Mar 31, 2017 73,000.00
Dec 31, 2016 97,000.00
Sep 30, 2016 132,000.00
Jun 30, 2016 140,000.00
Mar 31, 2016 160,000.00
Dec 31, 2015 180,000.00
Sep 30, 2015 200,000.00
Jun 30, 2015 213,000.00
API Access

Larimar Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=LRMR&period=max&api_key=YOUR_API_KEY